Dynamic contrast enhanced ultrasound for therapy monitoring

European Journal of Radiology

Volumn 84, Issue 9, 2015, Pages 1650-1657

  Hudson, John M ^a   Williams, Ross ^b   Tremblay Darveau, Charles ^a   Sheeran, Paul S ^a   Milot, Laurent ^a   Bjarnason, Georg A ^c   Burns, Peter N ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Canada   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anti angiogenic therapy; Anti inflammatory therapy; Cancer; Contrast enhanced ultrasound; Inflammatory bowel disease; Therapy assessment

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIINFLAMMATORY AGENT; CONTRAST MEDIUM;

ANTIANGIOGENIC THERAPY; ARTICLE; BLOOD FLOW; BLOOD VOLUME; BOLUS INJECTION; CANCER THERAPY; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DYNAMIC CONTRAST ENHANCED ULTRASOUND; ECHOGRAPHY; HEART MUSCLE PERFUSION; HUMAN; IMAGE PROCESSING; INFLAMMATORY BOWEL DISEASE; MEAN TRANSIT TIME; MICROBUBBLE; MICROVASCULATURE; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; REPRODUCIBILITY; SIGNAL NOISE RATIO; THREE DIMENSIONAL IMAGING; TREATMENT RESPONSE; VENOUS CIRCULATION; COLOR DOPPLER FLOWMETRY; IMAGE ENHANCEMENT; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; NEOPLASMS;

CONTRAST MEDIA; HUMANS; IMAGE ENHANCEMENT; IMAGING, THREE-DIMENSIONAL; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; MICROBUBBLES; NEOPLASMS; REPRODUCIBILITY OF RESULTS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 84939270718     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2015.05.013     Document Type: Review

References (54)

1. I.M.E. Desar, C.M.L. Van Herpen, H.W.M. Van Laarhoven, J.O. Barentsz, W.J.G. Oyen, and W.T.A. Van Der Graaf Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy Cancer Treat. Rev. 35 2009 309 321
2. G.A. Bjarnason, B. Khalil, J.M. Hudson, R. Williams, L.M. Milot, M. Atri, A. Kiss, and P.N. Burns Outcomes in patients with metastatic renal cell cancer treated with individualized sunitinib therapy: correlation with dynamic microbubble ultrasound data and review of the literature Urol. Oncol. 32 2014 480 487
3. N. Lassau, L. Chapotot, B. Benatsou, V. Vilgrain, M. Kind, J. Lacroix, M. Cuinet, S. Taieb, R. Aziza, A. Sarran, C. Labbe, B. Gallix, O. Lucidarme, Y. Ptak, L. Rocher, L.M. Caquot, S. Chagnon, D. Marion, A. Luciani, J. Uzan-Augui, and S. Koscielny Standardization of dynamic contrast-enhanced ultrasound for the evaluation of antiangiogenic therapies: the French multicenter support for innovative and expensive techniques study Invest. Radiol. 47 2012 711 716
4. C.F. Dietrich, M.A. Averkiou, J.M. Correas, N. Lassau, E. Leen, and F. Piscaglia An EFSUMB introduction into dynamic contrast-enhanced ultrasound (DCE-US) for quantification of tumour perfusion Ultraschall Med. 33 2012 344 351
5. E. Leen, M. Averkiou, M. Arditi, P. Burns, D. Bokor, T. Gauthier, Y. Kono, and O. Lucidarme Dynamic contrast enhanced ultrasound assessment of the vascular effects of novel therapeutics in early stage trials Eur. Radiol. 22 2012 1442 1450
6. R.M. Weisskoff, D. Chesler, J.L. Boxerman, and B.R. Rosen Pitfalls in MR measurement of tissue blood flow with intravascular tracers: which mean transit time? Magn. Reson. Med. 29 1993 553 559
7. C. Strouthos, M. Lampaskis, V. Sboros, A. Mcneilly, and M. Averkiou Indicator dilution models for the quantification of microvascular blood flow with bolus administration of ultrasound contrast agents IEEE Trans. Ultrason. Ferroelectr. Freq. Control 57 2010 1296 1310
8. N. Rognin, and M. Arditi In-vivo perfusion quantification by contrast ultrasound: validation of the use of linearized video data vs. raw RF data IEEE Int. Ultrason. Symp. 2008 1690 1693
9. M. Gauthier, F. Tabarout, I. Leguerney, M. Polrot, S. Pitre, P. Peronneau, and N. Lassau Assessment of quantitative perfusion parameters by dynamic contrast-enhanced sonography using a deconvolution method: an in vitro and in vivo study J. Ultrasound Med. 31 2012 595 608
10. M. Gauthier Impact of the arterial input function on microvascularization parameter measurements using dynamic contrast-enhanced ultrasonography World J. Radiol. 4 2012 291 301
11. M. Lamuraglia, S.L. Bridal, M. Santin, G. Izzi, O. Rixe, A. Paradiso, and O. Lucidarme Clinical relevance of contrast-enhanced ultrasound in monitoring anti-angiogenic therapy of cancer: current status and perspectives Crit. Rev. Oncol. Hematol. 73 2010 202 212
12. K. Wei, A. Jayaweera, S. Firoozan, A. Linka, D. Skyba, and S. Kaul Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion Circulation 97 1998 473 483
13. R. Williams, J.M. Hudson, B.A. Lloyd, A.R. Sureshkumar, G. Lueck, L. Milot, M. Atri, G.A. Bjarnason, and P.N. Burns Dynamic microbubble contrast-enhanced US to measure tumor response to targeted therapy: a proposed clinical protocol with results from renal cell carcinoma patients receiving antiangiogenic therapy Radiology 260 2011 581 590
14. M. Krix, F. Kiessling, S. Vosseler, N. Farhan, M. Mueller, P. Bohlen, N. Fusenig, and S. Delorme Sensitive noninvasive monitoring of tumor perfusion during antiangiogenic therapy by intermittent bolus-contrast power Doppler sonography Cancer Res. 63 2003 8264 8270
15. R. Karshafian, P.N. Burns, and M.R. Henkelman Transit time kinetics in ordered and disordered vascular trees Phys. Med. Biol. 48 2003 3225 3237
16. T. Potdevin, J. Fowlkes, A. Moskalik, and P. Carson Analysis of refill curve shape in ultrasound contrast agent studies Med. Phys. 31 2004 623 632
17. M. Arditi, P.J. Frinking, X. Zhou, and N.G. Rognin A new formalism for the quantification of tissue perfusion by the destruction-replenishment method in contrast ultrasound imaging IEEE Trans. Ultrason. Ferroelectr. Freq. Control 53 2006 1118 1129
18. J.M. Hudson, R. Karshafian, and P.N. Burns Quantification of flow using ultrasound and microbubbles: a disruption replenishment model based on physical principles IEEE Ultrasonics Symp. 2006 1588 1591
19. J.M. Hudson, R. Williams, B. Lloyd, M. Atri, T.K. Kim, G.A. Bjarnason, and P.N. Burns Improved flow measurement using microbubble contrast agents and disruption-replenishment: clinical application to tumour monitoring Ultrasound Med. Biol. 37 2011 1210 1221
20. J.M. Hudson, R. Williams, R. Karshafian, L. Milot, M. Atri, P.N. Burns, and G.A. Bjarnason Quantifying vascular heterogeneity using microbubble disruption-replenishment kinetics in patients with renal cell cancer Invest. Radiol. 49 2013 116 123
21. R. Jirik, K. Nylund, O. Gilja, M. Mezl, V. Harabis, R. Kolar, M. Standara, and T. Taxt Ultrasound perfusion analysis combining bolus-tracking and burst-replenishment IEEE Trans. Ultrason. Ferroelectr. Freq. Control 60 2013 310 319
22. N. Lassau, L. Chami, B. Benatsou, P. Peronneau, and A. Roche Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: a new diagnostic tool to evaluate the early effects of antiangiogenic treatment Europ. Radiol. Suppl. 17 2007 89 98
23. N. Lassau, S. Koscielny, P. Opolon, and T. De Baere Evaluation of contrast-enhanced color Doppler ultrasound for the quantification of angiogenesis in vivo Invest. Radiol. 36 2001 50 55
24. J. Lindner, P. Dayton, M. Coggins, K. Ley, J. Song, K. Ferrara, and S. Kaul Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles Circulation 102 2000 531 538
25. K. Nylund, R. Jirik, M. Mezl, S. Leh, T. Hausken, F. Pfeffer, S. Ødegaard, T. Taxt, and O.H. Gilja Quantitative contrast-enhanced ultrasound comparison between inflammatory and fibrotic lesions in patients with Crohn's disease Ultrasound Med. Biol. 39 2013 1197 1206
26. F. Saevik, K. Nylund, T. Hausken, S. Ødegaard, and O.H. Gilja Bowel perfusion measured with dynamic contrast-enhanced ultrasound predicts treatment outcome in patients with Crohn's disease Inflamm. Bowel Dis. 20 2014 2029 2037
27. M. Gerlinger, A. Rowan, S. Horswell, J. Larkin, D. Endesfelder, E. Gronroos, P. Martinez, N. Matthews, A. Stewart, and P. Tarpey Intratumor heterogeneity and branched evolution revealed by multiregion sequencing N. Engl. J. Med. 366 2012 883 892
28. N. Rognin, M. Arditi, L. Mercier, P. Frinking, M. Schneider, G. Perrenoud, A. Anaye, J. Meuwly, and F. Tranquart Parametric imaging for characterizing focal liver lesions in contrast-enhanced ultrasound IEEE Trans. Ultrason. Ferroelectr. Freq. Control 57 2010 2503 2511
29. J.M. Hudson, K. Leung, and P.N. Burns The lognormal perfusion model for disruption replenishment measurements of blood flow: in vivo validation Ultrasound Med. Biol. 37 2011 1571 1578
30. A. Perperidis, D. Thomas, M. Averkiou, C. Duncan, M. McNeilly, and V. Sboros Automatic Dissociation Between Microvasculature and Larger Vessels for Ultrasound Contrast Imaging 2014 Engineering in Medicine and Biology Society (EMBC) Chicago, IL 5076 5079
31. C. Tremblay-Darveau, R. Williams, L. Milot, M. Bruce, and P.N. Burns Combined perfusion and doppler imaging using plane-wave nonlinear detection and microbubble contrast agents IEEE Trans. Ultrason. Ferroelectr. Freq. Control 61 2014 1998 2000
32. K. Hoyt, A. Sorace, and R. Saini Quantitative mapping of tumor vascularity using volumetric contrast-enhanced ultrasound Invest. Radiol. 47 2011 167 174
33. M.X. Tang, H. Mulvana, T. Gauthier, A. Lim, D. Cosgrove, R. Eckersley, and E. Stride Quantitative contrast-enhanced ultrasound imaging: a review of sources of variability Interface Focus 1 2011 520
34. D.E. Goertz, N. de Jong, and A.F.W. van der Steen Attenuation and size distribution measurements of definity (TM) and manipulated definity (TM) populations Ultrasound Med. Biol. 33 2007 1376 1388
35. B. Helfield, X. Huo, R. Williams, and D. Goertz The effect of preactivation vial temperature on the acoustic properties of definity Ultrasound Med. Biol. 38 2012 1298 1305
36. M. Gauthier Estimation of intra-operator variability in perfusion parameter measurements using DCE-US WJR 3 2011 70 81
37. M.A. Averkiou, M. Lampaskis, K. Kyriakopoulou, D. Skarlos, G. Klouvas, C. Strouthos, and E.L. Leen Quantification of tumor microvascularity with respiratory gated contrast enhanced ultrasound for monitoring therapy Ultrasound Med. Biol. 36 2010 68 77
38. J. Folkman Angiogenesis: an organizing principle for drug discovery? Nat. Rev. Drug. Discovery 6 2007 273 286
39. N. Ferrara, and R. Kerbel Angiogenesis as a therapeutic target Nature 438 2005 967 974
40. R.J. Motzer, T.E. Hutson, P. Tomczak, M.D. Michaelson, R.M. Bukowski, S. Oudard, S. Negrier, C. Szczylik, R. Pili, G.A. Bjarnason, X. Garcia-Del-Muro, J.A. Sosman, E. Solska, G. Wilding, J.A. Thompson, S.T. Kim, I. Chen, X. Huang, and R.A. Figlin Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma J. Clin. Oncol. 27 2009 3584 3590
41. E.J. Abel, S.H. Culp, N.M. Tannir, S.F. Matin, P. Tamboli, E. Jonasch, and C.G. Wood Primary tumor response to targeted agents in patients with metastatic renal cell carcinoma Eur. Urol. 59 2011 10 15
42. E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, L. Rubinstein, L. Shankar, L. Dodd, R. Kaplan, D. Lacombe, and J. Verweij New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur. J. Cancer 45 2009 228 247
43. W.A. Weber Assessing tumor response to therapy J. Nucl. Med. 50 2009 1S 10S
44. M. Mancuso, R. Davis, S. Norberg, S. O'Brien, B. Sennino, T. Nakahara, V. Yao, T. Inai, P. Brooks, and B. Freimark Rapid vascular regrowth in tumors after reversal of VEGF inhibition J. Clin. Invest. 116 2006 2610 2621
45. J. Lindner, J. Song, A. Jayaweera, J. Sklenar, and S. Kaul Microvascular rheology of Definity microbubbles after intra-arterial and intravenous administration J. Am. Soc. Echocardiogr. 15 2002 396 403
46. R. Pollard, A. Broumas, E. Wisner, S. Vekich, and K. Ferrara Quantitative contrast enhanced ultrasound and CT assessment of tumor response to antiangiogenic therapy in rats Ultrasound Med. Biol. 33 2007 235 245
47. K. Niermann, A. Fleischer, J. Huamani, T. Yankeelov, D. Kim, W. Wilson, and D. Hallahan Measuring tumor perfusion in control and treated murine tumors correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography J. Ultrasound Med. 26 2007 749 756
48. N. Lassau, V. Vilgrain, S. Taieb, J. Lacroix, R. Aziza, M. Cuinet, J. Soria, L. Chapotot, and S. Koscielny Evaluation with DCE-US of antiangiogenic treatments in 539 patients allowing the selection of one surrogate marker correlated to overall survival J. Clin. Oncol. 30 Suppl. 2012 http://meetinglibrary.asco.org/content/95901-114 (abstract 4618)
49. E. Quaia, L.D. Paoli, T. Stocca, B. Cabibbo, F. Casagrande, and M.A. Cova The value of small bowel all contrast enhancement after sulfur hexafluoride-filled microbubble injection to differentiate inflammatory from fibrotic strictures in patients with Crohn's disease Ultrasound Med. Biol. 38 2012 1324 1332
50. E. Quaia, B. Cabibbo, L. De Paoli, W. Toscano, G. Poillucci, and M. Cova The value of time-intensity curves obtained after microbubble contrast agent injection to discriminate responders from non-responders to anti-inflammatory medication among patients with Crohn's disease Eur. Radiol. 23 2013 1650 1659
51. T. Ripollés, M.J. Martínez, J.M. Paredes, E. Blanc, L. Flors, and F. Delgado Crohn disease: correlation of findings at contrast-enhanced US with severity at endoscopy Radiology 253 2009 241
52. C. Girlich, D. Schacherer, E.M. Jung, A. Schreyer, and R. Büttner Comparison between a clinical activity index (Harvey-Bradshaw-Index), laboratory inflammation markers and quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound in Crohn's disease Eur. J. Radiol. 81 2012 1105 1109
53. L. Guidi, A. De Franco, I. De Vitis, A. Armuzzi, S. Semeraro, I. Roberto, A. Papa, E. Bock, G. Gasbarrini, and G. Fedelii Contrast-enhanced ultrasonography with SonoVue after infliximab therapy in Crohn's disease Eur. Rev. Med. Pharmacol. Sci. 10 2006 23
54. F. Piscaglia, C. Nolsøe, C. Dietrich, D. Cosgrove, O. Gilja, M. Bachmann Nielsen, T. Albrecht, L. Barozzi, M. Bertolotto, and O. Catalano The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications Ultraschall Med. 33 2012 33